Roche Holding AG

RHO5

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    103,605

Roche Holding AG News & Analysis

stocks

Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?

‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,415.00100.20-1.18%
CAC 407,226.98199.90-2.69%
DAX 4019,033.64414.96-2.13%
Dow JONES (US)43,910.98382.15-0.86%
FTSE 1008,025.7799.42-1.22%
HKSE19,846.88580.05-2.84%
NASDAQ19,281.4017.36-0.09%
Nikkei 22539,287.7988.30-0.22%
NZX 50 Index12,641.80107.56-0.84%
S&P 5005,983.9917.36-0.29%
S&P/ASX 2008,152.40103.20-1.25%
SSE Composite Index3,421.9748.10-1.39%

Market Movers